New Risk Score Helps Predict IntraAbdominal Abscess in Crohn's Disease
A new fiveparameter risk score accurately predicts intraabdominal abscess in Crohn's disease CD patients presenting to the emergency department ED researchers from Israel report. Reuters Health...
View ArticleImmutep Presents Positive IMP761 Preclinical Results at 14th Congress of...
SYDNEY Australia March 07 2019 GLOBE NEWSWIRE Immutep Limited ASX IMM; NASDAQ IMMP Immutep or the Company a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune...
View ArticleBoehringer Ingelheim's novel antibody shows potential to transform treatment...
Published in The New England Journal of Medicine new data show single dose BI 655130 rapidly cleared symptoms of a rare and potentially lifethreatening form of pustular psoriasis1 BI 655130 is an...
View ArticleLandos Biopharma to Present at Upcoming Investor Conferences
Landos Biopharma Inc. a clinicalstage biopharmaceutical company focused on the discovery and development of safer and more effective firstinclass oral therapeutics for patients with autoimmune diseases...
View ArticleFungus Usually Found on Skin Might Play a Role in Crohn's Disease
NewsA fungus commonly found in human hair follicles also resides in the gut where it may worsen intestinal disorders in patients with a certain genetic makeup.
View ArticleLOral Announces Partnership with Microbial Genomics Leader uBiome to Advance...
The partnership between the two companies will be introduced at L&39;Or&233;al&39;s Know Your Skin exhibit at The Fast Company Grill in Austin Texas between March 8th and 11th 2019SAN...
View Article$ARNA Presented New Phase 2 Data for Etrasimod and Olorinab at the 14th...
$ARNA Presented New Phase 2 Data for Etrasimod and Olorinab at the 14th Congress of European Crohn's and Colitis Organisation...
View ArticleSkin Fungi May Be Tied to Bowel Disease
FRIDAY March 8 2019 Crohn's disease involves inflammation of the digestive tract. But new research into its causes is focusing on fungi commonly found on the skin.These microscopic fungi called...
View ArticleDrug Concentrations Immunogenicity Predict AntiTNF Treatment Failure
About onequarter of patients with active luminal Crohn's disease CD do not respond to antitumor necrosis factor TNF drugs while about twothirds don't achieve remission according to new research....
View ArticleCelltrion Healthcare showcases initial data from yearlong study for...
The subcutaneous SC formulation of CTP13 was comparable in terms of efficacy and safety with intravenous IV formulation for the treatment of Crohns disease up until week 54 indicating that CTP13 SC...
View ArticleVedolizumab Entyvio Achieves Superior Rates of Clinical Remission vs....
Vedolizumab superior to adalimumab in achieving clinical remission and mucosal healing at week 52 in patients with moderately to severely active ulcerative colitis Takeda Pharmaceutical Company Limited TS
View ArticleHuman medicines European public assessment report EPAR Flixabi infliximab...
Human medicines European public assessment report EPAR Flixabi infliximab Spondylitis AnkylosingArthritis RheumatoidCrohn DiseaseColitis UlcerativeArthritis PsoriaticPsoriasis Date of authorisation...
View ArticleCelgene Submits Application to EMA for Ozanimod for the Treatment of...
New Drug Application submission to U.S. FDA on track for end of March Celgene Corporation NASDAQCELG today announced that the Company has submitted a Marketing Authorization Application to the European...
View ArticleNew Phase 3 STELARAÂ ustekinumab Data Show Positive Results as Maintenance...
44week UNIFI data presented for the first time during plenary session at 14th Congress of the European Crohns and Colitis Organisation Abstract OP37 New data evaluating STELARAÂ ustekinumab therapy on...
View ArticleAbivax SA ABVXFR ABX464 sustained safety and benefit in inflammatory bowel
goetzpartners securities Limited11March2019 1454 GMTBSTFree to access research and investor meetings in a postMiFID2 world.This research report is intended for use only by persons who qualify as...
View ArticlePredictImmune Announce Formal Entry of PredictSURE IBD into the NICE...
Evaluation by the Diagnostic Assessment Programme provides independent support and validation of PredictImmunes first product addressing IBD PredictImmune developers of pioneering prognostic tools for...
View ArticleT Cell Clonal Expansion Linked to Postop Recurrence of Crohn's in Smokers
Among smokers with Crohn's disease increased T cell clonal expansion especially in the CD8 compartment is exaggerated and is associated with an increased rate of disease recurrence after ileocolonic...
View ArticleNewly Published Study in Mice Finds a Fasting Mimicking Diet May Reduce or...
In mice and human cells periodic cycles of fastinglike conditions appear to trigger intestinal regeneration more effectively than wateronly fasting A team of researchers from the University of Southern...
View ArticleMedical News Today Stelara vs. Humira What's the difference
Stelara and Humira are two biologics that help treat immune conditions such as psoriatic arthritis and Crohns disease. In this article we look at the similarities and differences in their effects...
View Article